LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells
Year: 2019
Type: article
Abstract: BACKGROUND: Chemotherapy resistance is one of the main causes of recurrence in colorectal cancer (CRC) patients and leads to poor prognosis. Long noncoding RNAs (lncRNAs) have been reported to regulate chemoresistance. We aimed to determine the role of the lncRNA small nucleolar RNA host gene 6 (SNHG6) in CRC cell chemoresistance. METHODS: Cell drug sensitivity tests and flow cytometry were performed to analyze CRC cell chemoresistance. Animal models were used to determine chemoresistance in vivo, and micro RNA (miRNA) binding sites were detected by dual-luciferase reporter assays. Bioinformatics analysis was performed to predict miRNAs binding to SNHG6 and target genes of miR-26a-5p. SNHG6/miR-26a-5p/ULK1 axis and autophagy-related proteins were detected by qRT-PCR and western blotting. Furthermore, immunofluorescence was employed to confirm the presence of autophagosomes. RESULTS: SNHG6 enhanced CRC cell resistance to 5-fluorouracil (5-FU), promoted autophagy, inhibited 5-FU-induced apoptosis, and increased 5-FU resistance in vivo. Bioinformatics analysis showed that miR-26a-5p might bind to SNHG6 and target ULK1, and dual-luciferase reporter assays confirmed this activity. qRT-PCR and western blotting showed that SNHG6 was able to negatively regulate miR-26a-5p but correlated positively with ULK1. CONCLUSION: SNHG6 may promote chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in CRC cells.
Source: Cancer Cell International
Authors: Xinke Wang(Funding acquisition, Methodology, Writing – original draft), Zhixian Lan(Methodology, Writing – review & editing), Juan He(Validation), Qiuhua Lai(Validation), Xiang Yao(Software), Qingyuan Li(Validation), Yongfeng Liu(Formal analysis), Huasheng Lai(Software), Chuncai Gu(Formal analysis), Qun Yan(Investigation), Yuxin Fang(Data curation), Yue Zhang(Visualization), Aimin Li(Conceptualization, Supervision), Side Liu(Conceptualization, Funding acquisition, Project administration, Resources)
Institutions: Nanfang Hospital, Southern Medical University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,680
Awards: G1149685029, G3527506392, G3833045022
OpenAlex ID: W2972642798
